WO2008105384A1 - シトルリン含有錠剤 - Google Patents
シトルリン含有錠剤 Download PDFInfo
- Publication number
- WO2008105384A1 WO2008105384A1 PCT/JP2008/053233 JP2008053233W WO2008105384A1 WO 2008105384 A1 WO2008105384 A1 WO 2008105384A1 JP 2008053233 W JP2008053233 W JP 2008053233W WO 2008105384 A1 WO2008105384 A1 WO 2008105384A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- citrulline
- salt
- tablet
- active ingredient
- containing tablet
- Prior art date
Links
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 title abstract 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 title abstract 3
- 235000013477 citrulline Nutrition 0.000 title abstract 3
- 229960002173 citrulline Drugs 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
アルギニンや配合される他の成分が有する種々の有用な機能を体内で発揮させることができ、かつ打錠性や保存安定性に優れた錠剤の開発が望まれている。
シトルリンまたはその塩と他の有効成分とを含有する錠剤。他の有効成分が、アミノ酸(但し、シトルリンを除く)またはその塩、有機酸またはその塩および動植物粉末からなる群から選ばれる1以上の成分である前記錠剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009501235A JPWO2008105384A1 (ja) | 2007-02-26 | 2008-02-26 | シトルリン含有錠剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-044954 | 2007-02-26 | ||
JP2007044954 | 2007-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008105384A1 true WO2008105384A1 (ja) | 2008-09-04 |
Family
ID=39721216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/053233 WO2008105384A1 (ja) | 2007-02-26 | 2008-02-26 | シトルリン含有錠剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2008105384A1 (ja) |
WO (1) | WO2008105384A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010270111A (ja) * | 2009-04-21 | 2010-12-02 | Taisho Pharmaceutical Co Ltd | アルギニン含有錠剤 |
JP2012139124A (ja) * | 2010-12-28 | 2012-07-26 | House Foods Corp | ニンニク成分含有飲料及びニンニク成分による風味の調整を行う方法 |
CN102885311A (zh) * | 2012-10-19 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | 一种缓解体力疲劳的保健食品组合物及其制备方法 |
JP2013509395A (ja) * | 2009-10-28 | 2013-03-14 | モデュテック エス.エー. | アミノ酸および植物を含む調製物およびアルコール解毒におけるその活性 |
JP2013060406A (ja) * | 2011-09-15 | 2013-04-04 | Kyowa Hakko Bio Co Ltd | 脳疲労改善用経口剤 |
EP2637505A4 (en) * | 2010-10-19 | 2014-04-09 | K L R M Llc | COMPOSITIONS AND METHOD FOR TREATING EFFECTIVE DYSFUNCTION |
CN103734724A (zh) * | 2013-12-31 | 2014-04-23 | 勾大卉 | 玛咖山楂咀嚼片 |
CN104435536A (zh) * | 2014-11-11 | 2015-03-25 | 武汉名实生物医药科技有限责任公司 | 能延缓衰老、改善性功能、抗疲劳的复方制剂的制备方法 |
JPWO2013122188A1 (ja) * | 2012-02-15 | 2015-05-18 | 協和発酵バイオ株式会社 | 血管内皮機能低下の予防または改善剤 |
JP2016121194A (ja) * | 2016-04-05 | 2016-07-07 | 協和発酵バイオ株式会社 | 脳疲労改善用経口剤 |
WO2019022216A1 (ja) * | 2017-07-28 | 2019-01-31 | 株式会社明治 | 筋力向上用アミノ酸組成物 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01180823A (ja) * | 1988-01-13 | 1989-07-18 | Sawai Seiyaku Kk | 脳障害処置剤 |
US6028107A (en) * | 1997-02-27 | 2000-02-22 | Waugh; William Howard | Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection |
US20010056068A1 (en) * | 1998-03-04 | 2001-12-27 | Kristof Chwalisz | Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives |
JP2005518361A (ja) * | 2001-11-27 | 2005-06-23 | ブルジンスキー,スタニスロー・アール | 細胞傷害的化学療法の毒性作用を軽減するために有用な、アミノ酸およびリボフラビンの配合物 |
WO2005077349A1 (ja) * | 2004-02-17 | 2005-08-25 | Otsuka Pharmaceutical Co., Ltd. | ヒトβディフェンシン産生促進剤 |
WO2006002096A2 (en) * | 2004-06-18 | 2006-01-05 | Vivo Therapeutics, Inc. | Low doses of l-citrulline for treating diseases |
US20060046982A1 (en) * | 2004-08-26 | 2006-03-02 | Waugh William H | Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease |
JP2006089487A (ja) * | 2005-10-03 | 2006-04-06 | Nara Institute Of Science & Technology | シトルリンを含有するdna切断防止剤、活性酸素障害に起因する疾患の治療薬または予防薬、抗酸化食品添加物 |
US20060247315A1 (en) * | 2003-07-08 | 2006-11-02 | Biocodex | Method of treating intestinal disorders with citrulline |
WO2007000985A1 (ja) * | 2005-06-27 | 2007-01-04 | Kyowa Hakko Kogyo Co., Ltd. | ヘモグロビン尿症またはミオグロビン尿症の予防または治療用組成物 |
WO2007023931A1 (ja) * | 2005-08-25 | 2007-03-01 | Kyowa Hakko Kogyo Co., Ltd. | 血中アルコール濃度上昇抑制用組成物 |
WO2007066642A1 (ja) * | 2005-12-05 | 2007-06-14 | Kyowa Hakko Kogyo Co., Ltd. | 皮膚の乾燥予防または改善用経口剤 |
JP2008050352A (ja) * | 2006-07-27 | 2008-03-06 | Ezaki Glico Co Ltd | 睡眠改善剤 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5124913B2 (ja) * | 2005-06-27 | 2013-01-23 | パナソニック株式会社 | 覚醒装置 |
-
2008
- 2008-02-26 JP JP2009501235A patent/JPWO2008105384A1/ja active Pending
- 2008-02-26 WO PCT/JP2008/053233 patent/WO2008105384A1/ja active Application Filing
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01180823A (ja) * | 1988-01-13 | 1989-07-18 | Sawai Seiyaku Kk | 脳障害処置剤 |
US6028107A (en) * | 1997-02-27 | 2000-02-22 | Waugh; William Howard | Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection |
US20010056068A1 (en) * | 1998-03-04 | 2001-12-27 | Kristof Chwalisz | Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives |
JP2005518361A (ja) * | 2001-11-27 | 2005-06-23 | ブルジンスキー,スタニスロー・アール | 細胞傷害的化学療法の毒性作用を軽減するために有用な、アミノ酸およびリボフラビンの配合物 |
US20060247315A1 (en) * | 2003-07-08 | 2006-11-02 | Biocodex | Method of treating intestinal disorders with citrulline |
WO2005077349A1 (ja) * | 2004-02-17 | 2005-08-25 | Otsuka Pharmaceutical Co., Ltd. | ヒトβディフェンシン産生促進剤 |
WO2006002096A2 (en) * | 2004-06-18 | 2006-01-05 | Vivo Therapeutics, Inc. | Low doses of l-citrulline for treating diseases |
US20060046982A1 (en) * | 2004-08-26 | 2006-03-02 | Waugh William H | Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease |
WO2007000985A1 (ja) * | 2005-06-27 | 2007-01-04 | Kyowa Hakko Kogyo Co., Ltd. | ヘモグロビン尿症またはミオグロビン尿症の予防または治療用組成物 |
WO2007023931A1 (ja) * | 2005-08-25 | 2007-03-01 | Kyowa Hakko Kogyo Co., Ltd. | 血中アルコール濃度上昇抑制用組成物 |
JP2006089487A (ja) * | 2005-10-03 | 2006-04-06 | Nara Institute Of Science & Technology | シトルリンを含有するdna切断防止剤、活性酸素障害に起因する疾患の治療薬または予防薬、抗酸化食品添加物 |
WO2007066642A1 (ja) * | 2005-12-05 | 2007-06-14 | Kyowa Hakko Kogyo Co., Ltd. | 皮膚の乾燥予防または改善用経口剤 |
JP2008050352A (ja) * | 2006-07-27 | 2008-03-06 | Ezaki Glico Co Ltd | 睡眠改善剤 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010270111A (ja) * | 2009-04-21 | 2010-12-02 | Taisho Pharmaceutical Co Ltd | アルギニン含有錠剤 |
JP2013509395A (ja) * | 2009-10-28 | 2013-03-14 | モデュテック エス.エー. | アミノ酸および植物を含む調製物およびアルコール解毒におけるその活性 |
EP2637505A4 (en) * | 2010-10-19 | 2014-04-09 | K L R M Llc | COMPOSITIONS AND METHOD FOR TREATING EFFECTIVE DYSFUNCTION |
US10406196B2 (en) | 2010-10-19 | 2019-09-10 | K.L.R.M., Llc | Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction |
JP2012139124A (ja) * | 2010-12-28 | 2012-07-26 | House Foods Corp | ニンニク成分含有飲料及びニンニク成分による風味の調整を行う方法 |
JP2013060406A (ja) * | 2011-09-15 | 2013-04-04 | Kyowa Hakko Bio Co Ltd | 脳疲労改善用経口剤 |
JPWO2013122188A1 (ja) * | 2012-02-15 | 2015-05-18 | 協和発酵バイオ株式会社 | 血管内皮機能低下の予防または改善剤 |
CN102885311A (zh) * | 2012-10-19 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | 一种缓解体力疲劳的保健食品组合物及其制备方法 |
CN103734724A (zh) * | 2013-12-31 | 2014-04-23 | 勾大卉 | 玛咖山楂咀嚼片 |
CN104435536A (zh) * | 2014-11-11 | 2015-03-25 | 武汉名实生物医药科技有限责任公司 | 能延缓衰老、改善性功能、抗疲劳的复方制剂的制备方法 |
JP2016121194A (ja) * | 2016-04-05 | 2016-07-07 | 協和発酵バイオ株式会社 | 脳疲労改善用経口剤 |
WO2019022216A1 (ja) * | 2017-07-28 | 2019-01-31 | 株式会社明治 | 筋力向上用アミノ酸組成物 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008105384A1 (ja) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008105384A1 (ja) | シトルリン含有錠剤 | |
IL198411A0 (en) | Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide | |
WO2008019871A3 (de) | Neue salze des wirkstoffs rasagilin | |
UA103386C2 (ru) | Высокомощные гербицидные композиции на основе солей глифосату и 2,4-d | |
GEP20156376B (en) | Solid herbicide compositions with built-in adjuvant | |
ATE381892T1 (de) | Guanidinoessigsäure als futtermittelzusatz | |
WO2007141392A3 (en) | Compositions comprising betulonic acid | |
WO2008037373A3 (de) | Verfahren zur bekämpfung von tierischen schädlingen oder phytopathogenen pilzen durch applikation einer agrochemischen zusammensetzung in das kultursubstrat, geeignete formulierung und ihre anwendung | |
EP2486793A3 (en) | Stable S-(+)-abscisic acid liquid and soluble granule formulations | |
TW200800939A (en) | Novel insecticides | |
WO2013093647A3 (en) | A pesticide and a method of controlling a wide variety of pests | |
WO2009103884A3 (fr) | Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures | |
BR112014010814A8 (pt) | composições de herbicida/fitoprotetor contendo amidas do ácido n-(tetrazol-5-il) aril carboxílico e amidas do ácido n-(triazol-5-il) aril carboxílico | |
WO2011066980A3 (en) | Oral dosage forms with reduced potential for drug abuse | |
WO2007014124A3 (en) | High drug load formulations and dosage forms | |
WO2009100101A3 (en) | Solid formulation of low melting active compound | |
WO2009102443A3 (en) | Octanoic acid formulations and methods of treatment using the same | |
WO2011082959A3 (de) | Herbizide mittel enthaltend flufenacet | |
EP2692723A8 (en) | Aryloxy dihalopropenyl ether compound and use thereof | |
MY153109A (en) | A solid pharmaceutical formulation | |
WO2009148252A3 (ko) | 뇌졸중 표적용 펩티드 및 이의 용도 | |
WO2008148474A3 (de) | Lösungen für die perfusion und konservierung von organen und geweben | |
WO2008074406A3 (de) | Penetrationsförderer für herbizide und safener | |
WO2011021818A3 (ko) | 피부 각질 줄기세포 증식용 조성물 | |
RU2006113043A (ru) | Регулятор роста и развития сельскохозяйственных культур |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08711962 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009501235 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08711962 Country of ref document: EP Kind code of ref document: A1 |